RHB-106 is a proprietary encapsulated formulation for bowel preparation.

RHB-106 was acquired from Sydney-based Giaconda [ASX: GIA] in August 2010.

RHB-106 is a proprietary, flavorless, odorless, solid oral encapsulated formulation intended for the preparation and cleansing of the gastrointestinal tract prior to the performance of abdominal procedures and diagnostic tests, such as colonoscopies, barium enemas or virtual colonoscopies, as well as surgical interventions, such as laparotomies.

RHB-106 can be taken with water and avoids patient exposure to the often unpalatable taste of current products.

A Phase 2a study with a previous formulation of the RHB-106 actives was concluded in Australia with 62 patients demonstrating significantly improved patient response and comparable bowel cleansing, potentially allowing for an unobstructed procedure with reduced side-effects and improved compliance.